Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Athanasios D Anastasilakis

Showing results (71-80 of 156) with videos related to

Pageof 16
Sort By:
Pediatric Blood & Cancer|May 7, 2011
Reduced bone mineral density in adult patients with Langerhans cell histiocytosisPolyzois Makras, Evangelos Terpos, George Kanakis, et al.
Calcified Tissue International|February 10, 2011
No effect of rosuvastatin in the zoledronate-induced acute-phase responsePolyzois Makras, Athanasios D Anastasilakis, Stergios A Polyzos, et al.
Journal of Clinical Medicine|April 3, 2021
The Impact of Antiosteoporotic Drugs on Glucose Metabolism and Fracture Risk in Diabetes: Good or Bad News?Athanasios D Anastasilakis, Elena Tsourdi, Gaia Tabacco, et al.
Hormones (Athens, Greece)|June 3, 2025
Diagnosis and management of primary hyperparathyroidism: recommendations from the Bone Section of the Hellenic Endocrine SocietyAthanasios D Anastasilakis, Maria P Yavropoulou, Evanthia Kassi, et al.
Hormones (Athens, Greece)|June 27, 2025
Diagnosis and management of hypoparathyroidism: recommendations of the working group of the Bone Section of the Hellenic Endocrine SocietyEvanthia Kassi, Fotini Adamidou, Maria P Yavropoulou, et al.
European Journal of Endocrinology|November 13, 2016
Expression of microRNAs that regulate bone turnover in the serum of postmenopausal women with low bone mass and vertebral fracturesMaria P Yavropoulou, Athanasios D Anastasilakis, Polyzois Makras, et al.
Metabolism: Clinical and Experimental|May 13, 2018
Regulation of the activins-follistatins-inhibins axis by energy status: Impact on reproductive functionNikolaos Perakakis, Jagriti Upadhyay, Wael Ghaly, et al.
European Journal of Endocrinology|February 27, 2008
Acute changes in serum osteoprotegerin and receptor activator for nuclear factor-kappaB ligand levels in women with established osteoporosis treated with teriparatideAthanasios D Anastasilakis, Dimirtios G Goulis, Stergios A Polyzos, et al.
The Journal of Clinical Endocrinology and Metabolism|November 7, 2014
Rationale for the application of RANKL inhibition in the treatment of Langerhans cell histiocytosisPolyzois Makras, Maria Salagianni, Kyriakos Revelos, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 9, 2022
Embryo Quality May Be Associated With Serum Inhibin B Levels but Not With Serum or Follicular Fluid Levels of Other Components of the Activin-Follistatin-Inhibin AxisEirini Bouzoni, Eleftherios Gavriil, Athanasios D Anastasilakis, et al.
Pageof 16

Showing results (71-80 of 156) with videos related to

Sort By:
Pageof 16
Pediatric Blood & Cancer|May 7, 2011
Reduced bone mineral density in adult patients with Langerhans cell histiocytosisPolyzois Makras, Evangelos Terpos, George Kanakis, et al.
Calcified Tissue International|February 10, 2011
No effect of rosuvastatin in the zoledronate-induced acute-phase responsePolyzois Makras, Athanasios D Anastasilakis, Stergios A Polyzos, et al.
Journal of Clinical Medicine|April 3, 2021
The Impact of Antiosteoporotic Drugs on Glucose Metabolism and Fracture Risk in Diabetes: Good or Bad News?Athanasios D Anastasilakis, Elena Tsourdi, Gaia Tabacco, et al.
Hormones (Athens, Greece)|June 3, 2025
Diagnosis and management of primary hyperparathyroidism: recommendations from the Bone Section of the Hellenic Endocrine SocietyAthanasios D Anastasilakis, Maria P Yavropoulou, Evanthia Kassi, et al.
Hormones (Athens, Greece)|June 27, 2025
Diagnosis and management of hypoparathyroidism: recommendations of the working group of the Bone Section of the Hellenic Endocrine SocietyEvanthia Kassi, Fotini Adamidou, Maria P Yavropoulou, et al.
European Journal of Endocrinology|November 13, 2016
Expression of microRNAs that regulate bone turnover in the serum of postmenopausal women with low bone mass and vertebral fracturesMaria P Yavropoulou, Athanasios D Anastasilakis, Polyzois Makras, et al.
Metabolism: Clinical and Experimental|May 13, 2018
Regulation of the activins-follistatins-inhibins axis by energy status: Impact on reproductive functionNikolaos Perakakis, Jagriti Upadhyay, Wael Ghaly, et al.
European Journal of Endocrinology|February 27, 2008
Acute changes in serum osteoprotegerin and receptor activator for nuclear factor-kappaB ligand levels in women with established osteoporosis treated with teriparatideAthanasios D Anastasilakis, Dimirtios G Goulis, Stergios A Polyzos, et al.
The Journal of Clinical Endocrinology and Metabolism|November 7, 2014
Rationale for the application of RANKL inhibition in the treatment of Langerhans cell histiocytosisPolyzois Makras, Maria Salagianni, Kyriakos Revelos, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 9, 2022
Embryo Quality May Be Associated With Serum Inhibin B Levels but Not With Serum or Follicular Fluid Levels of Other Components of the Activin-Follistatin-Inhibin AxisEirini Bouzoni, Eleftherios Gavriil, Athanasios D Anastasilakis, et al.
Pageof 16